Verismo Therapeutics, a clinical-stage CAR T company developing a novel KIR-CAR platform technology, today announced its participation at the upcoming Society of Immunotherapy in Cancer (SITC)...

The global Automotive Hall of Fame (AHF) is proud to announce that John Krafcik has been selected as the recipient of the 2026 Mobility Innovator Award, presented by EY, recognizing his visionary...

Synchrony (NYSE: SYF) Chief Financial Officer, Brian J. Wenzel, will participate in a fireside chat at the KBW Fintech Payments Conference on Wednesday, November 12, 2025 at 10:10 a.m. (Eastern Time).

Autonomous Systems, Advanced Machinery, Talking Tractor Concept and Mixed-Fleet Management Platform Take Center Stage HANOVER, Germany, Nov. 5, 2025 /PRNewswire/ -- AGCO (NYSE: AGCO), a global...

HCB301 is a first-in-class tri-specific immunotherapy targeting SIRPα-CD47, PD-1/PD-L1, and TGFβ; it shows potent macrophage activation, T-cell restoration, and tumor microenvironment remodeling...